Efficacy of Vasopressin Antagonism in Heart Failure Out- come Study with Tolvaptan
(2010) Causes of death and re hospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Out- come Study with Tolvaptan (EVEREST) program.
( 2010 ) Causes of death and re hospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction : results from Efficacy of Vasopressin Antagonism in Heart Failure Out- come Study with Tolvaptan ( EVEREST ) program .